Beneficial Effect of Prone Positioning During Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019.


Journal

Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501

Informations de publication

Date de publication:
01 02 2022
Historique:
pubmed: 29 9 2021
medline: 15 2 2022
entrez: 28 9 2021
Statut: ppublish

Résumé

The study investigated the impact of prone positioning during venovenous extracorporeal membrane oxygenation support for coronavirus disease 2019 acute respiratory failure on the patient outcome. An observational study of venovenous extracorporeal membrane oxygenation patients. We used a multistate survival model to compare the outcomes of patients treated with or without prone positioning during extracorporeal membrane oxygenation, which incorporates the dynamic nature of prone positioning and adjusts for potential confounders. Seventy-two international institutions participating in the Coronavirus Disease 2019 Critical Care Consortium international registry. Coronavirus disease 2019 patients who were supported by venovenous extracorporeal membrane oxygenation during the study period. None. There were 232 coronavirus disease 2019 patients at 72 participating institutions who were supported with venovenous extracorporeal membrane oxygenation during the study period from February 16, 2020, to October 31, 2020. Proning was used in 176 patients (76%) before initiation of extracorporeal membrane oxygenation and in 67 patients (29%) during extracorporeal membrane oxygenation. Survival to hospital discharge was 33% in the extracorporeal membrane oxygenation prone group versus 22% in the extracorporeal membrane oxygenation supine group. Prone positioning during extracorporeal membrane oxygenation support was associated with reduced mortality (hazard ratio, 0.31; 95% CI, 0.14-0.68). Our study highlights that prone positioning during venovenous extracorporeal membrane oxygenation support for refractory coronavirus disease 2019-related acute respiratory distress syndrome is associated with reduced mortality. Given the observational nature of the study, a randomized controlled trial of prone positioning on venovenous extracorporeal membrane oxygenation is needed to confirm these findings.

Identifiants

pubmed: 34582415
doi: 10.1097/CCM.0000000000005296
pii: 00003246-202202000-00012
pmc: PMC8796833
doi:

Types de publication

Journal Article Multicenter Study Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

275-285

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.

Déclaration de conflit d'intérêts

Dr. Jacobs received funding from SpecialtyCare and the American Academy of Dermatology. Dr. Heinsar received funding via PhD scholarship from the University of Queensland. Dr. Bassi’s institution received funding from Fisher & Paykel. Dr. Dalton received funding from Innovative Extracorporeal Membrane Oxygenation (ECMO) Concepts; she disclosed the off-label product use of ECMO equipment. The remaining authors have disclosed that they do not have any potential conflicts of interest.

Références

Alhazzani W, Møller MH, Arabi YM, et al.: Surviving Sepsis Campaign: Guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Crit Care Med. 2020; 48:e440–e469
Bartlett RH, Ogino MT, Brodie D, et al.: Initial ELSO guidance document: ECMO for COVID-19 patients with severe cardiopulmonary failure. ASAIO J. 2020; 66:472–474
Jacobs JP, Stammers AH, St Louis J, et al.: Extracorporeal membrane oxygenation in the treatment of severe pulmonary and cardiac compromise in coronavirus disease 2019: Experience with 32 patients. ASAIO J. 2020; 66:722–730
Alnababteh M, Hashmi MD, Vedantam K, et al.: Extracorporeal membrane oxygenation for COVID-19 induced hypoxia: Single-center study. Perfusion. 2021; 36:564–572
Barbaro RP, MacLaren G, Boonstra PS, et al.; Extracorporeal Life Support Organization: Extracorporeal membrane oxygenation support in COVID-19: An international cohort study of the Extracorporeal Life Support Organization registry. Lancet. 2020; 396:1071–1078
Guérin C, Reignier J, Richard JC, et al.; PROSEVA Study Group: Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013; 368:2159–2168
Coppo A, Bellani G, Winterton D, et al.: Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): A prospective cohort study. Lancet Respir Med. 2020; 8:765–774
Munshi L, Fralick M, Fan E: Prone positioning in non-intubated patients with COVID-19: Raising the bar. Lancet Respir Med. 2020; 8:744–745
Paul V, Patel S, Royse M, et al.: Proning in non-intubated (PINI) in times of COVID-19: Case series and a review. J Intensive Care Med. 2020; 35:818–824
Giani M, Martucci G, Madotto F, et al.: Prone positioning during venovenous extracorporeal membrane oxygenation in acute respiratory distress syndrome. A multicenter cohort study and propensity-matched analysis. Ann Am Thorac Soc. 2021; 18:495–501
Guervilly C, Prud’homme E, Pauly V, et al.: Prone positioning and extracorporeal membrane oxygenation for severe acute respiratory distress syndrome: Time for a randomized trial? Intensive Care Med. 2019; 45:1040–1042
Rubin R: Global effort to collect data on ventilated patients with COVID-19. JAMA. 2020; 323:2233–2234
COVID-19 Critical Care Consortium. Available at: https://www.covid-critical.com/ . Accessed November 26, 2020
Li Bassi G, Suen J, Barnett AG, et al.: The COVID-19 Critical Care Consortium observational study: Design and rationale of a prospective, international, multicenter, observational study. medRxiv. Preprint posted online June 2, 2020. doi: 10.1136/bmjopen-2020-041417
doi: 10.1136/bmjopen-2020-041417
Dunning JW, Merson L, Rohde GGU, et al.; ISARIC Working Group 3, ISARIC Council: Open source clinical science for emerging infections. Lancet Infect Dis. 2014; 14:8–9
Murthy S: Using research to prepare for outbreaks of severe acute respiratory infection. BMJ Global Health. 2019; 4:e001061
Hazard D, Kaier K, von Cube M, et al.: Joint analysis of duration of ventilation, length of intensive care, and mortality of COVID-19 patients: A multistate approach. BMC Med Res Methodol. 2020; 20:206
Noah MA, Peek GJ, Finney SJ, et al.: Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA. 2011; 306:1659–1668
Rilinger J, Zotzmann V, Bemtgen X, et al.: Prone positioning in severe ARDS requiring extracorporeal membrane oxygenation. Crit Care. 2020; 24:397
Wolkewitz M, Cooper BS, Bonten MJ, et al.: Interpreting and comparing risks in the presence of competing events. BMJ. 2014; 349:g5060
Lunn D, Jackson C, Best N, et al.: The Bugs Book: A Practical Introduction to Bayesian Analysis. Chapman & Hall/Crc Texts in Statistical Science. New York, Taylor & Francis, 2012
Wasserstein RL, Lazar NA: The ASA statement on p-values: Context, process, and purpose. Am Stat. 2016; 70:129–133
Therneau TM: A Package for Survival Analysis in R. 2020. Available at: https://CRAN.R-project.org/package=survival . Accessed November 11, 2020
Gray B: Cmprsk: Subdistribution analysis of Competing risks. 2020. Available at: https://CRAN.R-project.org/package=cmprsk . Accessed November 11, 2020
Barnett A: Analysis for CCCC. 2020. Available at: https://github.com/agbarnett/covid_cccc . Accessed November 11, 2020
Guerin C, Gaillard S, Lemasson S, et al.: Effects of systematic prone positioning in hypoxemic acute respiratory failure: A randomized controlled trial. JAMA. 2004; 292:2379–2387
Bloomfield R, Noble DW, Sudlow A: Prone position for acute respiratory failure in adults. Cochrane Database Syst Rev. 2015; 2015:CD008095
Mora-Arteaga JA, Bernal-Ramírez OJ, Rodríguez SJ: The effects of prone position ventilation in patients with acute respiratory distress syndrome. A systematic review and metaanalysis. Med Intensiva. 2015; 39:359–372
Munshi L, Del Sorbo L, Adhikari NKJ, et al.: Prone position for acute respiratory distress syndrome. A systematic review and meta-analysis. Ann Am Thorac Soc. 2017; 14:S280–S288
Pan C, Chen L, Lu C, et al.: Lung recruitability in COVID-19-associated acute respiratory distress syndrome: A single-center observational study. Am J Respir Crit Care Med. 2020; 201:1294–1297
Elharrar X, Trigui Y, Dols AM, et al.: Use of prone positioning in nonintubated patients with COVID-19 and hypoxemic acute respiratory failure. JAMA. 2020; 323:2336–2338
Voelker MT, Jahn N, Bercker S, et al.: [Prone positioning of patients during venovenous extracorporeal membrane oxygenation is safe and feasible]. Anaesthesist. 2016; 65:250–257
Kredel M, Bischof L, Wurmb TE, et al.: Combination of positioning therapy and venovenous extracorporeal membrane oxygenation in ARDS patients. Perfusion. 2014; 29:171–177
Culbreth RE, Goodfellow LT: Complications of prone positioning during extracorporeal membrane oxygenation for respiratory failure: A systematic review. Respir Care. 2016; 61:249–254
Garcia B, Cousin N, Bourel C, et al.; Lille Intensive Care COVID-19 group: Prone positioning under VV-ECMO in SARS-CoV-2-induced acute respiratory distress syndrome. Crit Care. 2020; 24:428

Auteurs

Akram M Zaaqoq (AM)

Department of Critical Care Medicine, MedStar Washington Hospital Center, Georgetown University, Washington, DC.

Adrian G Barnett (AG)

Australian Centre for Health Services Innovation (AusHSI) and Centre for Healthcare Transformation, School of Public Health & Social Work, Queensland University of Technology (QUT), Brisbane, QLD, Australia.

Matthew J Griffee (MJ)

Department of Anesthesiology, University of Utah School of Medicine, Salt Lake City, UT.

Graeme MacLaren (G)

Cardiothoracic Intensive Care, National University Hospital, National University of Singapore, Singapore.

Jeffrey P Jacobs (JP)

Congenital Heart Center, Department of Surgery, University of Florida, Gainesville, FL.

Silver Heinsar (S)

Critical Care Research Group, Faculty of Medicine, University of Queensland and The Prince Charles Hospital, Brisbane, QLD, Australia.

Jacky Y Suen (JY)

Critical Care Research Group, Faculty of Medicine, University of Queensland and The Prince Charles Hospital, Brisbane, QLD, Australia.

Gianluigi Li Bassi (GL)

Critical Care Research Group, Faculty of Medicine, University of Queensland and The Prince Charles Hospital, Brisbane, QLD, Australia.
'Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain.

John F Fraser (JF)

Critical Care Research Group, Faculty of Medicine, University of Queensland and The Prince Charles Hospital, Brisbane, QLD, Australia.
Adult Intensive Care Services, The Prince Charles Hospital, Brisbane, QLD, Australia.

Heidi J Dalton (HJ)

Department of Pediatrics, Inova Fairfax Hospital, Falls Church, VA.

Giles J Peek (GJ)

Congenital Heart Center, Department of Surgery, University of Florida, Gainesville, FL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH